LABORATORY CONTROL OF HEPARIN AND HEPARIN FRAGMENT TREATMENT - AN EXPERIMENTAL-STUDY

被引：5

作者：

DOUTREMEPUICH, C

LALANNE, MC

GUYOT, M

DOUTREMEPUICH, F

DESEZE, O

TOULEMONDE, F

机构：

来源：

SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1989年 / 15卷 / 04期

关键词：

D O I：

10.1055/s-2007-1002733

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：373 / 377

页数：5

共 35 条

[1] LACK OF CORRELATION BETWEEN INVITRO AND INVIVO ANTITHROMBOTIC ACTIVITY OF HEPARIN FRACTIONS AND RELATED-COMPOUNDS - HEPARAN-SULFATE AS AN ANTITHROMBOTIC AGENT INVIVO [J].

BIANCHINI, P ;

OSIMA, B ;

PARMA, B ;

NADER, HB ;

DIETRICH, CP .

THROMBOSIS RESEARCH, 1985, 40 (05) :597-607

[2] EFFECTS OF HEPARIN, ITS LOW-MOLECULAR WEIGHT FRACTIONS AND OTHER GLYCOSAMINOGLYCANS ON THROMBUS GROWTH-INVIVO [J].

BONEU, B ;

BUCHANAN, MR ;

CADE, JF ;

VANRYN, J ;

FERNANDEZ, FF ;

OFOSU, FA ;

HIRSH, J .

THROMBOSIS RESEARCH, 1985, 40 (01) :81-89

[3]

BRATT G, 1985, THROMB HAEMOSTASIS, V54, P813

[4]

BUCHANAN MR, 1985, BLOOD, V65, P198

[5]

CASU B, 1985, NOUV REV FR HEMATOL, V26, P24

[6]

CREMONESI P, 1987, Drugs of the Future, V12, P45

[7] WHAT IS THE BEST PLASMATIC ACTIVITY WHICH COULD BE CORRELATED WITH THE ANTITHROMBOTIC EFFECT OF HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN FRAGMENT [J].

DOUTREMEPUICH, C ;

CASTRIOTO, T ;

DESEZE, O ;

PEREIRA, F ;

DOUTREMEPUICH, F ;

ANNE, MC ;

TOULEMONDE, F .

THROMBOSIS RESEARCH, 1987, 48 (02) :245-251

[8] ARE MOLECULAR-WEIGHT AND ANTI-XA ACTIVITY SUFFICIENT TO PREDICT THE ANTITHROMBOTIC POWER OF HEPARIN FRACTIONS [J].

DOUTREMEPUICH, C ;

BOUSQUET, F ;

TOULEMONDE, F .

THROMBOSIS RESEARCH, 1986, 44 (05) :709-712

[9]

DOUTREMEPUICH C, 1985, ANN PHARM FR, V43, P161

[10] COMPARISON OF THE HEMORRHAGIC EFFECTS OF UNFRACTIONATED HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN FRACTION (CY-216) IN RABBITS [J].

DOUTREMEPUICH, C ;

TOULEMONDE, F ;

BOUSQUET, F ;

BONINI, F .

THROMBOSIS RESEARCH, 1986, 43 (06) :691-695

← 1 2 3 4 →